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Abstract Transcatheter Aortic Valve Implantation (TAVI)
is increasingly being used in patients with severe aortic
stenosis who are not candidates for surgery. ECG-gated
CT angiography (CTA) plays an important role in the
preoperative planning for these devices. As the number
of patients undergoing these procedures increases, a sub-
set of patients is being recognized who have contraindi-
cations to iodinated contrast medium, either due to a prior
severe allergic type reaction or poor renal function.
Another subgroup of patients with low flow and low gra-
dient aortic stenosis is being recognized that are usually
assessed for severity of aortic stenosis by stress echocar-
diography. There are contraindications to stress echocar-
diography and some of these patients may not be able to
undergo this test. Non-contrast MRI can be a useful
emerging modality for evaluating these patients. In this
article, we discuss the emerging indications of non-
contrast MRI in preoperative assessment for TAVI and
describe the commonly used MRI sequences. A compari-
son of the most important measurements obtained for
TAVI assessment on CTA and MRI from same subjects
is included.
Teaching Points
• MRI can be used for preoperative assessment of aortic
annulus.
• MRI is an alternate to CTA when iodinated contrast is
contraindicated.
• Measurements obtained by non-contrast MRI are similar to
contrast enhanced CTA.
• MRI can be used to assess severity of aortic stenosis.
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Background
Valvular heart disease is estimated to account for as many
as 20 % of cardiac surgical procedures performed in the
United States [1]. Transcatheter aortic valve implantation
(TAVI) has become an increasingly promising treatment
for high surgical risk patients with severe aortic stenosis.
TAVI has resulted in substantially reduced mortality and
morbidity compared to standard treatment methods in the
poor surgical risk patient subgroup [2]. It has become a
viable option in these patients with increasingly promising
short- and mid-term outcomes.
Pre-procedure imaging plays an important role in
assessing the anatomy of the aortic annulus, aorta, iliac
and femoral arteries in these patients, thereby preventing
patient-prosthesis mismatch and determining a suitable
vascular approach [3]. Accurate prosthesis-valve
matching is necessary not only to reduce the incidence
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and amount of paravalvular regurgitation (if the prosthetic
valve is too small), but also aortic rupture (when prosthet-
ic valve is too large). Analyzing the aorta and ilofemoral
arteries with attention to size, tortuosity, and calcification
determines the optimal prosthetic valve size and access
approach. Echocardiography, ECG-gated CT angiography
(CTA), and catheter angiography have been used for pre-
operative planning. Increasingly, CTA is playing an im-
portant role towards preoperative assessment of aortic an-
nular dimensions and aortic geometry for optimal pros-
thetic valve size and functions next to echocardiography
in aortic root evaluation. Evaluation of the peripheral vas-
culature is routinely being performed using helical CTA
of the abdomen and pelvis. However, iodinated CT con-
trast media cannot be administered to patients with se-
verely impaired renal function or severe contrast allergic
type reaction [4], and non-contrast CT obtained in such
cases is limited in its ability to evaluate non-calcified
p l a q u e s a nd l um i n a l d imen s i o n s i n v e s s e l s .
Echocardiography is of limited utility in the presence of
extensive vascular calcifications or when an optimum
acoustic window is not obtainable. In such patients, inva-
sive catheter angiography, transesophageal ultrasound [5],
invasive intravascular ultrasound, or low dose catheter CT
angiography [6] have been suggested as alternatives for
pre-procedure assessment. Aortic annulus sizing for TAVI
by transesophageal echocardiography (TEE) also avoids
the use of iodinated contrast. However, large annular size
measured by CTA or MRI but not TTE is predictive of
paravalvular leak [7]. Aortic regurgitation is the most fre-
quent post-procedural complication after TAVI. Any aor-
tic regurgitation is linked with increased late mortality [8].
A subset of patients is increasingly being recognized
when the gradient suggests less severe stenosis than the
calculated valve area. This can be due to a dilated ventri-
cle with low ejection fraction (EF) or small ventricle with
normal EF. In these patients, dobutamine stress echocar-
diography is used and the aortic valve is considered truly
stenotic if the maximum jet velocity rises over 4 m/s with
dobutamine-induced increase in stroke volume, whereas
the AVA remains less than 1.0 cm2 [9].
IRB approval was obtained for this study.
Non-contrast MRI
Non-contrast MRI is a noninvasive and radiation free diag-
nostic test that can provide critical pre-TAVI planning infor-
mation and, thus, replace the use of pre-procedure invasive
angiography or CTA. Advantages of MR include the ability
to provide both anatomic (annular diameters, perimeter, area)
measurements and quantify aortic valve stenosis (flow vol-
umes, peak velocities) with high accuracy [10]. Recent studies
have demonstrated that the information gained from bothMRI
and ECG-gated CTA in the pre-operative assessment of pa-
tients undergoing TAVI is reproducible [3, 7, 11–13]. MRI
provides numerically similar measurements in terms of annu-
lus size, left ventricular outflow tract (LVOT), and aortic valve
area when compared to TTE [11]. MRI can also provide ana-
tomic assessment of the aortic valve for identifying congenital
valvular abnormalities, visualization of cardiac structure &
function, and identification of atherosclerotic plaque, aneu-
rysm, or dissection in the ascending aorta.
Emerging indications for MRI
As the number of TAVI procedures increases, there will also be
an increase in the number of patients who cannot be optimally
evaluated with CTA, echocardiography, or stress echocardiog-
raphy. Thus, non-contrast MR may have an important role in
preoperative evaluation in the following groups of patients:
1. Patients with history of severe allergic type reaction to
intravenous iodinated contrast medium who cannot be
administered contrast medium for CTA.
Table 1 Important aortic annular measurements, which identify the optimal Edwards Sapien transcatheter heart valve based on CTA [38] and
echocardiography (http://www.edwards.com/eu/products/transcathetervalves/Pages/sapien3.aspx).









Sapien 23 mm 18-22/338-430 19-22 60-69 300-380 20.7 – 23.4
Sapien 26 mm 21-25/430-546 23-25 72-78.5 415-490 23.4 – 26.4
Sapien 29 mm 24-28/540-683 26-28 81.5-88 530-620 26.2 – 29.5
Sapien3: 20 mm 16-19 273-345 18.6-21
Sapien3: 23 mm 18-22 338-430 20.7-23.4
Sapien3: 26 mm 21-25 430-546 23.4-26.4
Sapien3: 29 mm 24-28 540-683 26.2-29.5
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2. Impaired renal function (acute kidney injury or chronic
kidney injury with serum creatinine > 2 mg/dL, or
GFR<30 mL/min/m2).
3. Evaluation of severity of aortic stenosis in patients with
poor acoustic window and low cardiac output/low gradi-
ent AS (aortic stenosis) with reduced left ventricular ejec-
tion fraction (LVEF).
4. Evaluating severity of aortic stenosis in patients with
moderate stenosis by echocardiography but symptomatic
for severe stenosis and who have contraindications for
stress echocardiography (Appendix A) [14].
Post-gadolinium delayed enhanced imaging has been used
to assess the severity of coronary artery disease in patients
undergoing TAVI, and it has been demonstrated that there is
decreased LVEF recovery after TAVI in the presence of sig-
nificant delayed enhancement prior to TAVI [15]. Use of
Gadolinium however is contraindicated in patients with poor
renal function. Gadolinium enhancedMRI is not necessary for
the preoperative measurements for TAVI.
Advantages of MRI
Advantages of MRI as compared to CT or catheter angiogra-
phy include: noninvasive and radiation-free imagingmodality,
anatomic assessment of the aortic valve for identifying
congenital valvular abnormalities, performing planimetry to
calculate aortic valve area, visualization of cardiac structures,
characterization of the ventricular mass and function, identi-
fying atherosclerotic plaque, aneurysm, or dissection in the
ascending aorta. The type and number of available transcath-
eter aortic valve have evolved and increased over time.
Identifying the optimal device and appropriate approach to
implant depends on a number of critical measurements.
Although there are publications reviewing the usefulness of
MRI, both before and after implantation, for the evaluation of
TAVI, these have mostly focused on only a few aspects of the
increasingly complex and comprehensive assessment needed
for complete assessment prior to TAVI. This article is based on
our experience of patients who underwent both contrast en-
hanced ECG-gated CTA and non-contrast MRI for preopera-
tive assessment for TAVI. It provides a comprehensive review
of the key measurements for the pre TAVI assessment as re-
ported on CTA (Tables 1 and 2), most useful acquisition se-
quences on a 1.5 T MR scanner (Table 3), and the imaging
parameters (Table 4) used for these sequences at our
institution.
Limitations of MRI
There are important limitations of MRI in preoperative assess-
ment for TAVI including multiple breath holds, longer scan












CoreValve 23 18–20 254.5–314.2 56.5–62.8 ≤34 mm ≥15/≥25
CoreValve 26 20–23 314.2–415.5 62.8–72.3 ≤40 mm ≥15/≥27
CoreValve 29 23–26 415.5–572.6 72.3–84.8 ≤43 mm ≥15/≥29
CoreValve 31 26–29 530.9–660.5 81.7–91.1 ≤43 mm ≥15/≥29
Table 3 Key MR sequence and their utility in pre-operative evaluation for TAVI
Sequence Purpose
Three-plane localizer Localize aortic valve plane
Axial SSFP non-ECG gated without contrast Identify potential ascending aorta and subclavian access sites,
determine size, calcification, and presence of aneurysmal dilatation of aorta
Breath held/free breathing 2D ECG-gated SSFP:
Coronal Aorta, LVOT and Aortic Root
Evaluate aortic annulus, aortic valve structure, and sinus height
Planimetry valve orifice area
SSFP ECG gated images: short axis stack Calculate ejection fraction, ventricular volumes and mass
Breath held/free breathing phase contrast at aortic orifice Calculate blood flow velocity, pressure gradient and flow volume across the aortic valve
Calculate aortic regurgitant volume
3-D Navigator assisted SSFP Coronary ostia height
Aortic diameter
T2 Black Blood Useful in presence of susceptibility artifacts from sternal wires or prosthetic valves
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time, and other contraindications as discussed in appendix B.
Howwell MRI assesses calcified plaques and porcelain aorta is
not known. At present, semi-automatic analysis software is
available for CT, but none is available for MRI. Not all patients
can undergo MRI, and there are certain absolute and relative
contraindications for MRI that the TAVI team (clinicians and
cardiac imagers) should also be aware of (Appendix B).
Aortic annulus
The aortic annulus is a virtual ring formed by connecting the
basal hinge points of the aortic valve leaflets. The annulus is
not a distinct histological entity or anatomical boundary, but
represents the smallest diameter in the blood path between the
left ventricle and aorta and represents the position for the
implanted prosthetic valve [16] (Fig. 1). Bright blood
(SSFP= steady state free precession) aortic root cine stack of
8–10 slices from diastole to systole is acquired parallel to the
valve plane (Movie 1). This plane can be prescribed by plan-
ning the acquisition perpendicular to the direction of flow in
aortic sinus on these two planes: coronal aorta and left ventri-
cle outflow tract (Fig. 2a, b, respectively). This plane is similar
to the suggested plane for performing planimetric assessment
of the aortic orifice [11, 13, 17] as well as for performing 2-D
phase contrast MRI measurements of aortic flow. Obtaining
such a plane ensures that annular area and diameter measure-
ments are obtained perpendicular to the axis of blood flow in
LVOT and aorta as has been described for aortic measure-
ments. As there is systolic descent of the annular plane, this
acquisition should always begin in the left ventricle outflow
tract. The annular plane is identified by the end systolic image
below the insertion of leaflets by scrolling through this cine
stack (Fig. 2c). This slice is used for assessing the minor &
major diameters, area, and perimeter of the annulus. Annular
diameters can also be obtained from a navigator-assisted free
breathing diastolic phase 3-D SSFP sequence [3]. Non-
contrast 3-D-FLASH MRA has been proposed to obtain dia-
stolic annular dimensions, and using a correction factor based
on systolic measurements from CTA in the same patients, a
systolic corrected annular dimension can be obtained [18].
Measurement of the annulus is important for correct selection
of prosthesis size, type, and to avoid damage of the annulus if
the valve is oversized and avoid paravalvular regurgitation if
the valve is undersized. Measurements including and exclud-
ing calcification are provided. Accurate measurement of
heavily calcified annulus remains challenging, and the best
method to measure such an annulus has not been determined.
In our practice, on both CTA and MRI, heavily calcified an-
nulus area and diameters are measured by including and ex-
cluding the calcification. In one study, using an in vivo model
of calcium containing rings, MRI measurements have been
demonstrated to be the most accurate for assessing the actual
dimensions compared to CT or 3-D echocardiography [19].
When there is still uncertainty, measurements obtained by
CTA/MRI are compared to annular sizing by calibrated bal-
loon aortic valvuloplasty [20, 21]. The degree of annular cal-
cification can also be assessed with MRI; however, how well
this assessment is compared to CT is not known. In our expe-
rience, a change in signal intensity of the aortic wall should be
sought as the presence of calcification leads to a darker inter-
face on SSFP sequences (Fig. 3).
Table 4 Parameters of the key MRI sequences on a 1.5 T MRI used at our institution
Sequence Flip Angle TE/TR Slice Thickness/Gap (mm)
Axial SSFP non-gated without contrast 45 1.4/3.4 6/0
Breath held/free breathing 2D ECG-gated SSFP: Coronal Aorta, LVOT and Aortic Root 45 1.4/3.4 5/0
T2 Black Blood 90 41/1791 8/0
Breath held/free breathing phase contrast at aortic orifice 25 2.7/5.6 8
3D Navigator assisted SSFP 75 1.8/4 2
Fig. 1 Pictorial depiction of the aortic root complex demonstrating the
location of the annulus, aortoannular, ventriculoarterial and sinotubular
junction
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Protruding annular calcifications > 4 mm and adherent cal-
cification >6mm (particularly left-sided) or calcifications with
an Agatston score of > 3000 [22] are important predictors of
paravalvular leaks after TAVI [23]. Comparative CT and MRI
studies of heavily calcified annulus and aortic plaques have
not been done. In our experience, on MRI, measurement
should be obtained from the outer edge to the outer edge. In
case of suspected porcelain aorta, a non-contrast CTshould be
obtained to better characterize the degree and extent of calci-
fication. Evaluation of this aortic root cine stack also helps
identify nodular thickening in the valve leaflets, annulus,
LVOT, and for the presence of aortomitral continuity
calcification/thickening (Fig. 2).
Coronary ostia
The distance from the annulus to the coronary ostia is of
importance to prevent occlusion of the coronary arteries
by the displacement of the native aortic valve leaflets by
the prosthesis. Risk of coronary ostia occlusion is less
with the CoreValve prosthesis than with the Edwards
Sapien prosthesis. For the latter, minimum distance values
of 10–14 mm between the coronary ostia and leaflet
insertion are usually suggested. A 3-D SSFP free breath-
ing stack obtained in late diastole with a respiratory
navigator can be used to assess the height of coronary
ostia from the annular plane (Fig. 3a-b, c-d: comparative
images from CTA in same patient).
Aortic valve
Detailed anatomic assessment of the aortic valve can distin-
guish tricuspid vs. bicuspid, or the quadricuspid valve. TAVI
has been successfully performed in selected high-risk patients
with severe bicuspid aortic valve stenosis [24]. The severity
of aortic stenosis is mostly quantified by transthoracic or
transesophageal echocardiogram. In patients with low flow
and low gradient but clinically suspected severe stenosis, do-
butamine stress TTE is used to augment flow and unmask
severe stenosis. Stress TTE may be contraindicated in some
patients (Appendix A). Aortic stenosis can be quantified on
MRI by different methods. Planimetry of maximal visible
valve opening in systole on MRI (Fig. 4) correlate well with
planimetry measurements obtained on CT [7, 11, 17]. Severe
aortic stenosis is suggested when the aortic valve area is
<1 cm2. The valve leaflets can be evaluated on the 2-D
ECG-gated SSFP images (Fig. 5). Stenosis calculation based
on the Hakki formula (aortic valve area = cardiac flow/√max-
imum gradient) correlate well with measurements obtained
from echocardiography [25]. In addition, the velocity ratio
Fig. 2 Acquisition on MRI for
aortic annular plane to measure
diameters, area, and perimeter.
Aortic root cine stack is
prescribed from coronal aorta (a)
and left ventricle outflow tract
views (b). Systolic image where
the luminal diameter is widest, in
a location just below the insertion
of the valve leaflets (c) is
identified as the annular slice.
Corresponding annular image
from the same patient obtained
from ECG-gated CTA demon-
strates similar measurement of
annular area (d)
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based on peak velocity in the LVOT and aortic sinuses can
also be calculated from two separate 2-D phase contrast MR
acquisitions. A velocity ratio of < 0.25 is compatible with
severe stenosis.
Aortic sinus
Measurements of the sinus of valsalva diameters and height
are critical for proper positioning of the device to ensure that
there is no infringement of the coronary ostia (Tables 1 and 2).
Sinus diameter and height measurement can be obtained from
breath held or free breathing SSFP sequences (Fig. 5 a-c, e-f:
comparable measurements in the same patient from CTA).
Sinotubular junction height is critical for proper positioning
of the device and verifying no infringement on coronary ostia
especially for CoreValve. Susceptibility artefacts can limit
evaluation of SSFP sequences in patients who have implant-
able devices or sternal wires from prior thoracic surgery. In
these cases, additional non-fat suppressed T2 black blood im-
ages (coronal plane prescribed to aorta for left, and sagittal
plane for right coronary artery) can be used to identify sinus
diameter, height, etc.
Aortic root
Aortic root orientation is critical for precise positioning of the
device, in particular for the CoreValve. Inappropriate alignment
Fig. 3 Assessment of coronary
ostial height on MRI. Navigator-
assisted 3-D SSFP stack of the
aortic root in the late diastolic
phase is acquired. Ostial height is
measured from the aortic valve
annular plane (a: left coronary
artery, c right coronary artery). In
the same patient corresponding
CT images (b: left coronary
artery, d right coronary artery).
ThisMRI sequence can be also be
used to assess sinus of valsalva
height and width. Note the dark
appearance of the anterior aortic
wall and the left ventricle outflow
tract due to extensive calcifica-
tions, easily seen on the
corresponding CTA images
Fig. 4 Assessment of aortic stenosis by planimetry. 2-D cine SSFP
acquisition parallel to the valve plane demonstrates the narrowest opening
of the aortic orifice. CT of the same patient also demonstrated similar
orifice area
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is associated with post-procedural complications such as device
malposition or distal embolization. Root angulation can be
measured on coronal non-gated SSFP MRI in relation to body
axis For example, if the root angle>30°, a subclavian arterial
approach cannot be used for CoreValve implantation [26].
Ascending aorta
Assessment of the thoracic aorta for plaque burden is impor-
tant. MRI is not optimal for assessment of aortic calcifications
[9]. On MRI, calcifications would lead to signal voids and,
hence, appear dark. Silveresa et al., studied carotid and femo-
ral artery plaques using MRI and FDG-PETCT and demon-
strated complementary values of these modalities. In this
study, lipid-rich plaques were more inflamed than either cal-
cified or collagen-rich plaques. For MRI, they measured the
plaque using T2 weighted sequence [27]. Noncalcified athero-
sclerotic plaque burden of the thoracic aorta may increase the
risk for acute renal injury post valve implantation. Aortic wall
thickness that exceeded≥2 mm is defined as a diseased seg-
ment [28]. Assessment of plaque thickness between echocar-
diography and CTA is good [29]. Noninvasive MRI also com-
pares well with TEE for the assessment of atherosclerotic
plaque thickness, extent, and composition [30]. Although
there are no comparative studies evaluating CT and MRI for
thickness of the aortic plaque, plaque thickness should be
noted and measured using suggested comparative studies,
i.e., distance between the aortic border and the point of
greatest luminal protrusion [30].
In addition, evaluating the tubular ascending aorta for any
aneurysm or ectasia is important for implanting a CoreValve.
Heights of the Edwards Sapien prostheses are between 15–
19 mm, and they do not extend beyond the aortic sinus; how-
ever, the height of the CoreValve is between 52–55 mm, and
these valves extend into the tubular ascending aorta.
Therefore, aortic diameter is measured for these at a distance
of 40 mm from the valve plane. Significant aneurysmal dila-
tation is considered a contraindication for TAVI using this
device [21]. All measurements of aortic diameter should be
obtained perpendicular to the axis of blood flow [31].
Transaortic access
The direct transaortic approach is considered as an alternative
endovascular access site in patients with unsuitable
iliofemoral anatomy. Measurement of the distance from the
ascending aorta access site to the skin and valve plane can be
performed using axial non-gated SSFP MRI. A favourable
puncture site is at the greater curve, typically the right lateral
side of aorta with the following criteria: absence of calcifica-
tion, atheroma, thrombi, and dissection flap or previous sur-
gery [32]. The minimal distance from the aortic annulus to this
Fig. 5 Diameters of sinuses of
valsalva measured on MRI. 2-D
SSFP of the aortic root in late
diastolic phase is identified from
the aortic root stack. Diameters
are measured in mid-sinus above
the aortic valve (a: noncoronary,
b: left and c right). In the same
patient corresponding CT images
(d: noncoronary, e: left coronary
and f: right coronary). Navigator-
assisted 3-D SSFP or T2 black
blood sequences can also be used
for these measurements
Insights Imaging (2016) 7:245–254 251
access site needs to be at least 5 cm. This access site needs to
be at least 1 cm distal to coronary venous grafts or foreign
bodies (Fig. 6). The relation of the ascending aorta to the
sternum helps in identifying the surgical approach. A mini J
sternotomy is preferred if the ascending aorta is in midline or
toward the left and >6 cm deep to the sternum. A mini right
thoracotomy is preferred if the ascending aorta is right sided
(>50 % of the aorta is present on the right of the sternal board-
er) at the level of the second intercostal space and is <6 cm
deep to the sternum [32]. Howwell are the calcified plaques or
porcelain aorta assessed with MRI compared to CT is not
known. Presence of calcification may cause loss of signal in
the aortic wall (Fig. 3). When porcelain aorta is suspected, a
non-contrast CT may be obtained for better evaluation.
Transapical access
The transapical approach is considered as an alternative
access site option for balloon expandable transcatheter
valves in patients with unsuitable iliofemoral, subclavian,
or aortic anatomy. The left ventricle (LV) apex is evalu-
ated for scar/prior infarct and thrombus. Measurements of
the LV apex from the sternum and skin surface can be
performed using axial non-gated SSFP MRI similar to
CTA (Fig. 7). Advantages of the transapical approach
compared to a transfemoral approach include more reli-
able coaxial alignment of the transcatheter valve with the
aortic annulus and greater ability to control delivery of the
valve [33].
Fig. 7 Assessment of left
ventricle apex on MRI. Location
of the apex in the intercostal space
and the distance of this access site
from the midline can be measured
and marked using axial non-gated
SSFP sequence (a). Same site
location by CTA in this patient (b)
Fig. 6 Identification of access
site in tubular ascending aortic for
transaortic implantation on MRI.
Skin to aortic distance measured
on axial non-gated SSFP
sequence (a) similar to CTA (b).
Access site on aorta to annular
plane distance measured from
multiplanar sagittal oblique
reformats obtained from the same
axial non-gated SSFP sequence
(c). Same measurement in this
patient obtained from CTA (d)
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Post TAVI paravalvular regurgitation
Aortic regurgitation (AR) is the most frequent post-
procedural complication after TAVI and is linked to ad-
verse outcomes and mortality. MRI is another quantitative
imaging modality that can be used to assess aortic regurgi-
tation after valve implantation. Transthoracic echocardiog-
raphy displays higher variability and significantly underes-
timates AVannulus size and underestimates AR when com-
pared to MRI [34, 35]. Compared to echocardiography,
quantitative measurement of AR by MRI demonstrates bet-
ter correlation with quantitative assessment by angiogra-
phy [36]. MRI may be the modality of choice when there
is discordance in grading AR by echocardiography [37].
Conclusion
Pre-TAVI planning using non-contrast MRI can play a pivotal
role in the assessment of the aortic root complex and thoracic
access sites in patients who cannot undergo a contrast en-
hanced CTA either due to severe allergic reaction or severely
impaired renal function. Free breathing or navigator-assisted
imaging can be performed in patients with dyspnoea. MRI
provides hemodynamic information with high accuracy and
good correlation with echocardiography. MRI can accurately
assess severity of the aortic stenosis when there is a discrepan-
cy between clinical findings and echocardiography (because of
low flow, poor acoustic window, or inability to perform a stress
study). Anatomic information obtained fromMRI is reproduc-
ible compared to ECG gated CTA. In the future, further studies
may also establish usefulness of non-contrast MRI towards
assessment of calcified plaques and peripheral vascular access.
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Appendix
A. Contraindications to stress echocardiography are: ventric-
ular arrhythmias, recent myocardial infarction (within 3 days),
unstable angina, significant left ventricular outflow obstruc-
tion, aortic dissection, and severe hypertension: systolic blood
pressure>180 diastolic blood pressure >100 mmHg or symp-
tomatic hypertension [14].
B. Relative contraindications for MRI are: Severe claustro-
phobia, in which medical sedation is contraindicated or unable
to resolve anxiety sufficiently, and life threatening severe ar-
rhythmias. Absolute contraindications are: aneurysm clips,
carotid artery vascular clamp, neurostimulator devices,
Insulin or infusion pump, implanted drug infusion device,
bone growth/fusion stimulator, Cochlear, or ear implant, and
ocular foreign bodies (i.e., metal shavings).
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
1. Bennett CJ, Maleszewski JJ, Araoz PA (2012) CTandMR imaging
of the aortic valve: radiologic-pathologic correlation.
Radiographics 32:1399–1420
2. Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-
valve implantation for aortic stenosis in patients who cannot under-
go surgery. N Engl J Med 363:1597–1607
3. Quail MA, Nordmeyer J, Schievano S, Reinthaler M, Mullen MJ,
Taylor AM (2012) Use of cardiovascular magnetic resonance im-
aging for TAVR assessment in patients with bioprosthetic aortic
valves: comparison with computed tomography. Eur J Radiol 81:
3912–3917
4. (2013) ACR Manual on contrast media
5. Pontone G, Andreini D, Bartorelli AL et al (2012) Aortic annulus
area assessment by multidetector computed tomography for
predicting paravalvular regurgitation in patients undergoing
balloon-expandable transcatheter aortic valve implantation: a com-
parison with transthoracic and transesophageal echocardiography.
Am Heart J 164:576–584
6. Joshi SB, Mendoza DD, Steinberg DH et al (2009) Ultra-low-dose
intra-arterial contrast injection for iliofemoral computed tomo-
graphic angiography. JACC Cardiovasc Imaging 2:1404–1411
7. Jabbour A, Ismail TF, Moat N et al (2011) Multimodality imaging
in transcatheter aortic valve implantation and post-procedural aortic
regurgitation: comparison among cardiovascular magnetic reso-
nance, cardiac computed tomography, and echocardiography. J
Am Coll Cardiol 58:2165–2173
8. Kodali SK, Williams MR, Smith CR et al (2012) Two-year out-
comes after transcatheter or surgical aortic-valve replacement. N
Engl J Med 366:1686–1695
9. Holmes DR Jr, Mack MJ, Kaul S et al (2012) 2012 ACCF/AATS/
SCAI/STS expert consensus document on transcatheter aortic valve
replacement: developed in collabration with the american heart as-
sociation, american society of echocardiography, european associ-
ation for cardio-thoracic surgery, heart failure society of america,
mended hearts, society of cardiovascular anesthesiologists, society
of cardiovascular computed tomography, and society for cardiovas-
cular magnetic resonance. J Thorac Cardiovasc Surg 144:e29–e84
10. Rajani R, Hancock J, Chambers JB (2012) The art of assessing
aortic stenosis. Heart 98(Suppl 4):iv14–iv22
11. La Manna A, Sanfilippo A, Capodanno D et al (2011)
Cardiovascular magnetic resonance for the assessment of patients
undergoing transcatheter aortic valve implantation: a pilot study. J
Cardiovasc Magn Reson 13:82
12. Koos R, Altiok E, Mahnken AH et al (2012) Evaluation of aortic
root for definition of prosthesis size bymagnetic resonance imaging
and cardiac computed tomography: implications for transcatheter
aortic valve implantation. Int J Cardiol 158:353–358
Insights Imaging (2016) 7:245–254 253
13. Paelinck BP, Van Herck PL, Rodrigus I et al (2011) Comparison of
magnetic resonance imaging of aortic valve stenosis and aortic root
to multimodality imaging for selection of transcatheter aortic valve
implantation candidates. Am J Cardiol 108:92–98
14. Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG
(2007) American society of echocardiography recommendations
for performance, interpretation, and application of stress echocardi-
ography. J Am Soc Echocardiogr 20:1021–1041
15. Freixa X, Chan J, Bonan R et al (2015) Impact of coronary artery
disease on left ventricular ejection fraction recovery following
transcatheter aortic valve implantation. Catheter Cardiovasc Interv
85:450–458
16. Charitos EI, Sievers HH (2013) Anatomy of the aortic root: impli-
cations for valve-sparing surgery. Ann Cardiothorac Surg 2:53–56
17. Lopez-Mattei JC, Shah DJ (2013) When to consider cardiovascular
magnetic resonance in patients undergoing transcatheter aortic
valve replacement? Curr Opin Cardiol 28:505–511
18. Ruile P, Blanke P, Krauss T et al (2015) Pre-procedural assessment
of aortic annulus dimensions for transcatheter aortic valve replace-
ment: comparison of a non-contrast 3D MRA protocol with
contrast-enhanced cardiac dual-source CT angiography. Eur Heart
J Cardiovasc Imaging. doi:10.1093/ehjci/jev188
19. Tsang W, Bateman MG, Weinert L et al (2012) Accuracy of aortic
annular measurements obtained from three-dimensional echocardi-
ography, CTandMRI: human in vitro and in vivo studies. Heart 98:
1146–1152
20. Cerillo AG, Mariani M, Berti S, Glauber M (2012) Sizing the aortic
annulus. Ann Cardiothorac Surg 1:245–256
21. Achenbach S, Delgado V, Hausleiter J, Schoenhagen P, Min JK,
Leipsic JA (2012) SCCT expert consensus document on computed
tomography imaging before transcatheter aortic valve implantation
(TAVI)/transcatheter aortic valve replacement (TAVR). J
Cardiovasc Comput Tomogr 6:366–380
22. Koos R, Mahnken AH, Dohmen G et al (2011) Association of
aortic valve calcification severity with the degree of aortic regurgi-
tation after transcatheter aortic valve implantation. Int J Cardiol
150:142–145
23. Feuchtner G, Plank F, Bartel T et al (2013) Prediction of
paravalvular regurgitation after transcatheter aortic valve implanta-
tion by computed tomography: value of aortic valve and annular
calcification. Ann Thorac Surg 96:1574–1580
24. Wijesinghe N, Ye J, Rodes-Cabau J et al (2010) Transcatheter aortic
valve implantation in patients with bicuspid aortic valve stenosis.
JACC Cardiovasc Interv 3:1122–1125
25. Puymirat E, Chassaing S, Trinquart L et al (2010) Hakki's formula
for measurement of aortic valve area by magnetic resonance imag-
ing. Am J Cardiol 106:249–254
26. Litmanovich DE, Ghersin E, Burke DA, Popma J, Shahrzad M,
Bankier AA (2014) Imaging in Transcatheter Aortic Valve
Replacement (TAVR): role of the radiologist. Insights Imaging 5:
123–145
27. Silvera SS, Aidi HE, Rudd JH et al (2009) Multimodality imaging
of atherosclerotic plaque activity and composition using FDG-PET/
CT and MRI in carotid and femoral arteries. Atherosclerosis 207:
139–143
28. van Rosendael PJ, Kamperidis V, van der Kley F et al (2015)
Atherosclerosis burden of the aortic valve and aorta and risk of
acute kidney injury after transcatheter aortic valve implantation. J
Cardiovasc Comput Tomogr 9:129–138
29. Tenenbaum A, Garniek A, Shemesh J et al (1998) Dual-helical CT
for detecting aortic atheromas as a source of stroke: comparison
with transesophageal echocardiography. Radiology 208:153–158
30. Fayad ZA, Nahar T, Fallon JT et al (2000) In vivo magnetic reso-
nance evaluation of atherosclerotic plaques in the human thoracic
aorta: a comparison with transesophageal echocardiography.
Circulation 101:2503–2509
31. Hiratzka LF, Bakris GL, Beckman JA et al (2010) 2010
ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guide-
lines for the diagnosis and management of patients with thoracic
aortic disease: a report of the american college of cardiology
foundation/american heart association task force on practice guide-
lines, american association for thoracic surgery, american college
of radiology, american stroke association, society of cardiovascular
anesthesiologists, society for cardiovascular angiography and inter-
ventions, society of interventional radiology, society of thoracic
surgeons, and society for vascular medicine. Circulation 121:
e266–e369
32. Bapat V, Attia R (2012) Transaortic transcatheter aortic valve im-
plantation: step-by-step guide. Semin Thorac Cardiovasc Surg 24:
206–211
33. Walther T, Kempfert J (2012) Transapical vs. transfemoral aortic
valve implantation: Which approach for which patient, from a sur-
geon's standpoint. Ann Cardiothorac Surg 1:216–219
34. Orwat S, Diller GP, Kaleschke G et al (2014) Aortic regurgitation
severity after transcatheter aortic valve implantation is
underestimated by echocardiography compared with MRI. Heart
100:1933–1938
35. Ribeiro HB, Le Ven F, Larose E et al (2014) Cardiac magnetic
resonance versus transthoracic echocardiography for the assess-
ment and quantification of aortic regurgitation in patients undergo-
ing transcatheter aortic valve implantation. Heart 100:1924–1932
36. Sherif MA, Abdel-Wahab M, Beurich HW et al (2011)
Haemodynamic evaluation of aortic regurgitation after transcathe-
ter aortic valve implantation using cardiovascular magnetic reso-
nance. EuroIntervention 7:57–63
37. Lerakis S, Hayek SS, Douglas PS (2013) Paravalvular aortic leak
after transcatheter aortic valve replacement: current knowledge.
Circulation 127:397–407
38. Kasel AM, Cassese S, Bleiziffer S et al (2013) Standardized imag-
ing for aortic annular sizing: implications for transcatheter valve
selection. JACC Cardiovasc Imaging 6:249–262
254 Insights Imaging (2016) 7:245–254
